<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib102">
 <element-citation publication-type="journal" id="sref102">
  <person-group person-group-type="author">
   <name>
    <surname>Rey-Carrizo</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Torres</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Ma</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Barniol-Xicota</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Wu</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Naesens</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Degrado</surname>
    <given-names>W.F.</given-names>
   </name>
   <name>
    <surname>Lamb</surname>
    <given-names>R.A.</given-names>
   </name>
   <name>
    <surname>Pinto</surname>
    <given-names>L.H.</given-names>
   </name>
   <name>
    <surname>VÃ¡zquez</surname>
    <given-names>S.</given-names>
   </name>
  </person-group>
  <article-title>3-azatetracyclo[5.2.1.15,8.01,5]undecane Derivatives: from wild-type inhibitors of the M2 ion channel of influenza A virus to derivatives with potent activity against the V27A mutant</article-title>
  <source>J. Med. Chem.</source>
  <volume>56</volume>
  <year>2013</year>
  <fpage>9265</fpage>
  <lpage>9274</lpage>
  <pub-id pub-id-type="doi">10.1021/jm401340p</pub-id>
  <pub-id pub-id-type="pmid">24237039</pub-id>
 </element-citation>
</ref>
